The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist
Clinical trial NCT03397888 · COMPLETED
Trial details
- NCT number
- NCT03397888
- Sponsor
- Portola Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2018-01-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.